Allspring Global Investments Holdings, LLC Liquidia Corp Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$11.96 - $15.71 $514 - $675	-43 Reduced 82.69%	9 $0
Q1 2024 Apr 18, 2024	BUY	$11.35 - $16.73 $590 - $869	52 New	52 $0
Q2 2023 Jul 18, 2023	BUY	$6.63 - $9.9 $46,535 - $69,488	7,019 New	7,019 $55,000
Q4 2022 Jan 23, 2023	SELL	$4.68 - $6.54 $2,227 - $3,113	-476 Reduced 9.05%	4,785 $0
Q3 2022 Oct 26, 2022	BUY	$3.73 - $8.39 $19,623 - $44,139	5,261 New	5,261 $28,000

Others Institutions Holding LQDA

# of Institutions

163

Shares Held

36M

Call Options Held

1.79M

Put Options Held

380K

Patient Square Capital LP Menlo Park, CA

7.18M
Shares

$79.1 Million
40.01% of portfolio
Black Rock Inc. New York, NY

4.24M
Shares

$46.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$37.5 Million
0.0% of portfolio
Findell Capital Management LLC New York, NY

2.4M
Shares

$26.4 Million
13.89% of portfolio
State Street Corp Boston, MA

2.23M
Shares

$24.6 Million
0.0% of portfolio

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account